Controversies in hepatitis C therapy: Reactivation of hepatitis B virus
Sarah R. Lieber, Michael W. Fried – 31 October 2017
HCV treatment in patients with decompensated liver disease
Elizabeth C. Verna – 31 October 2017
Nonsurgical options for localized hepatocellular carcinoma
John Ha, Robert J. Wong – 31 October 2017
Normothermic machine perfusion of the liver
Hynek Mergental, Garrett R. Roll – 31 October 2017
Substance use disorders before and after liver transplantation
Jason L. Eccleston, Michael R. Lucey – 31 October 2017
Small‐for‐size syndrome in LT
Taizo Hibi, Yuko Kitagawa – 31 October 2017
Still ironing out the best way to diagnose infection
Peter V. Chin‐Hong – 31 October 2017
HCV treatment in patients with decompensated liver disease
Elizabeth C. Verna – 31 October 2017
The role of human cytochrome P450 2E1 in liver inflammation and fibrosis
Jun Xu, Hsiao‐Yen Ma, Shuang Liang, Mengxi Sun, Gabriel Karin, Yukinori Koyama, Ronglin Hu, Oswald Quehenberger, Nicholas O. Davidson, Edward A. Dennis, Tatiana Kisseleva, David A. Brenner – 30 October 2017 – Cytochrome P450 2E1 (CYP2E1) plays an important role in alcohol and toxin metabolism by catalyzing the conversion of substrates into more polar metabolites and producing reactive oxygen species. Reactive oxygen species‐induced oxidative stress promotes hepatocyte injury and death, which in turn induces inflammation, activation of hepatic stellate cells, and liver fibrosis.
Circulating bugs in blood in alcoholic liver disease!
Gabriel Perlemuter – 30 October 2017